Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + Capecitabine + RT in Rectal Cancer
NCT00869570Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Mar 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sorafenib in rectal cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Mar 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00869570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869570.